Searching for a Companion Star of Tycho's Type Ia Supernova with Optical Spectroscopic Observations

We report our first results of photometric and spectroscopic observations for Tycho's supernova remnant (SNR Tycho) to search for the companion star of a type Ia supernova (SN Ia). From photometric observations using Suprime-Cam on the Subaru Telescope, we have picked up stars brighter than 22 mag (in $V$-band) for spectroscopy, which are located within a circular region with the radius of 30" around the center of SNR Tycho. If the ejecta of young supernova remnants, such as SNR Tycho, have a sufficient amount of Fe I, we should be able to detect absorption lines at 3720 \AA and 3860 \AA associated with transitions from the ground state of Fe I in the spectrum of the companion star. To identify the companion star of a SN Ia using these characteristic absorption lines of Fe I, we made optical low-resolution spectroscopy of their targets using FOCAS on the Subaru Telescope. In our spectroscopic observations, we obtained spectra of 17 stars in the SNR Tycho region and compare them with template stellar spectra. We detect significant absorption lines from two stars at 3720 \AA. Since widths of their absorption lines are broad, it is likely that the detected absorptions are due to Fe I in the expanding ejecta of SNR Tycho. However, none of stars exhibits a clear red wing in the observed profiles of the absorption, though a star in the background of the SNR should show it. Hence, we suggest another interpretation that the detected absorption lines might be caused by the peculiarity of stars. A star named Tycho(E) has the absorption line at 3720 \AA and its projected position is close to the center of SNR Tycho. Based on our observations, Tycho(E) is a new candidate as the companion star of Tycho's supernova.Comment: 17 pages, 28 figures, accepted for publication in PAS

Holographic assembly of quasicrystalline photonic heterostructures

Quasicrystals have a higher degree of rotational and point-reflection symmetry than conventional crystals. As a result, quasicrystalline heterostructures fabricated from dielectric materials with micrometer-scale features exhibit interesting and useful optical properties including large photonic bandgaps in two-dimensional systems. We demonstrate the holographic assembly of two-dimensional and three-dimensional dielectric quasicrystalline heterostructures, including structures with specifically engineered defects. The highly uniform quasiperiodic arrays of optical traps used in this process also provide model aperiodic potential energy landscapes for fundamental studies of transport and phase transitions in soft condensed matter systems.Comment: 3 pages, 3 figures, submitted to Optics Expres

Isotropic photonic band gap and anisotropic structures in transmission spectra of two-dimensional 5-fold and 8-fold symmetric quasiperiodic photonic crystals

We measured and calculated transmission spectra of two-dimensional quasiperiodic photonic crystals (PCs) based on a 5-fold (Penrose) or 8-fold (octagonal) symmetric quasiperiodic pattern. The photonic crystal consisted of dielectric cylindrical rods in air placed normal to the basal plane on vertices of tiles composing the quasiperiodic pattern. An isotropic photonic band gap (PBG) appeared in the TM mode, where electric fields were parallel to the rods, even when the real part of a dielectric constant of the rod was as small as 2.4. An isotropic PBG-like dip was seen in tiny Penrose and octagonal PCs with only 6 and 9 rods, respectively. These results indicate that local multiple light scattering within the tiny PC plays an important role in the PBG formation. Besides the isotropic PBG, we found dips depending on the incident angle of the light. This is the first report of anisotropic structures clearly observed in transmission spectra of quasiperiodic PCs. Based on rod-number and rod-arrangement dependence, it is thought that the shapes and positions of the anisotropic dips are determined by global multiple light scattering covering the whole system. In contrast to the isotropic PBG due to local light scattering, we could not find any PBGs due to global light scattering even though we studied transmission spectra of a huge Penrose PC with 466 rods.Comment: One tex file for manuscript and 12 PNG files for figures consisting of Fig.1a-d, 2,3, ...

Host selection of hematophagous leeches (Haemadipsa japonica): Implications for iDNA studies

The development of an efficient and cost‐effective method for monitoring animal populations or biodiversity is urgently needed, and invertebrate‐derived DNA (iDNA) may offer a promising tool for assessing the diversity and other ecological information of vertebrates. We studied the host species of a hematophagous leech (Haemadipsa japonica) in Yakushima by genetic barcoding and compared the results with those for mammal composition revealed by camera trapping. We analyzed 119 samples using two sets of primers by Sanger sequencing and one set of primer by next generation sequencing. The proportion of the samples that were successfully sequenced and identified to at least one species was 11.8–24.3%, depending on the three different methods. In all of these three methods, most of the samples were identified as sika deer (18/20, 6/15 and 16/29) or human (2/20, 7/15 and 21/29). The nonhuman mammal host species composition was significantly different from that estimated by camera trapping. Sika deer was the main host, which may be related with their high abundance, large body size and terrestriality. Ten samples included DNA derived from multiple species of vertebrates. This may be due to the contamination of human DNA, but we also found DNA from deer, Japanese macaque and a frog in the same samples, suggesting the mixture of the two meals in the gut of the leech. Using H. japonica‐derived iDNA would not be suitable to make an inventory of species, but it may be useful to collect genetic information on the targeted species, due to their high host selectivity

Characterization of PvuRts1I endonuclease as a tool to investigate genomic 5–hydroxymethylcytosine

In mammalian genomes a sixth base, 5-hydroxymethylcytosine (hmC), is generated by enzymatic oxidation of 5-methylcytosine (mC). This discovery has raised fundamental questions about the functional relevance of hmC in mammalian genomes. Due to their very similar chemical structure, discrimination of the rare hmC against the far more abundant mC is technically challenging and to date no methods for direct sequencing of hmC have been reported. Here, we report on a purified recombinant endonuclease, PvuRts1I, which selectively cleaves hmC-containing sequences. We determined the consensus cleavage site of PvuRts1I as hmCN11–12/N9–10G and show first data on its potential to interrogate hmC patterns in mammalian genomes

Trace and antitrace maps for aperiodic sequences, their extensions and applications

We study aperiodic systems based on substitution rules by means of a transfer-matrix approach. In addition to the well-known trace map, we investigate the so-called `antitrace' map, which is the corresponding map for the difference of the off-diagonal elements of the 2x2 transfer matrix. The antitrace maps are obtained for various binary, ternary and quaternary aperiodic sequences, such as the Fibonacci, Thue-Morse, period-doubling, Rudin-Shapiro sequences, and certain generalizations. For arbitrary substitution rules, we show that not only trace maps, but also antitrace maps exist. The dimension of the our antitrace map is r(r+1)/2, where r denotes the number of basic letters in the aperiodic sequence. Analogous maps for specific matrix elements of the transfer matrix can also be constructed, but the maps for the off-diagonal elements and for the difference of the diagonal elements coincide with the antitrace map. Thus, from the trace and antitrace map, we can determine any physical quantity related to the global transfer matrix of the system. As examples, we employ these dynamical maps to compute the transmission coefficients for optical multilayers, harmonic chains, and electronic systems.Comment: 13 pages, REVTeX, now also includes applications to electronic systems, some references adde

Subthalamic deep brain stimulation in Parkinson's disease with SNCA mutations: Based on the follow-up to 10 years

Backgrounds: Although the short-term efficacy of bilateral subthalamic deep brain stimulation (DBS) has been reported in a limited number of Parkinson's disease (PD) patients with SNCA mutations, there are no data for long-term outcome. Methods: This multicenter retrospective study investigated previously reported PD patients with SNCA mutations, implanted with bilateral subthalamic DBS. We compared demographic and clinical data at baseline and last follow-up. Clinical data of motor and nonmotor symptoms and motor fluctuation were collected up to 10 years from DBS surgery. Results: Among four subjects, three had SNCA duplication and one had c.158C.A (p.A53E) mutation. The mean post-implantation follow-up duration was 5.4 +/- 3.7 years. All patients with SNCA duplication showed favorable outcome, although one died from breast cancer 1.5 years after DBS. The patient with the missense mutation became wheelchair-bound due to progressed axial, cognitive and psychiatric symptoms after 3.5 years from DBS despite the benefit on motor fluctuation. Conclusion: Based on findings in our small cohort, subthalamic DBS could be beneficial for motor fluctuation in PD patients with SNCA mutations, especially those with SNCA duplication, and cognitive and psychiatric symptoms are important for the long-term outcome of subthalamic DBS.</p

Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies

<p>Abstract</p> <p>Background</p> <p>YN968D1 (Apatinib) selectively inhibits phosphorylation of VEGFR-2 and tumor angiogenesis in mice model. The study was conducted to determine the maximum tolerated dose (MTD), safety profile, pharmacokinetic variables, and antitumor activity in advanced solid malignancies.</p> <p>Methods</p> <p>This dose-escalation study was conducted according to the Chinese State Food and Drug Administration (SFDA) recommendations in patients with advanced solid tumors to determine the MTD for orally administered apatinib. Doses of continuously administered apatinib were escalated from 250 mg. Treatment continued after dose-escalation phase until withdrawal of consent, intolerable toxicities, disease progression or death.</p> <p>Results</p> <p>Forty-six patients were enrolled. Hypertension and hand-foot syndrome were the two dose-limiting toxicities noted at dose level of 1000 mg. MTD was determined to be 850 mg once daily. Pharmacokinetic analysis showed early absorption with a half-life of 9 hours. The mean half-life was constant over all dose groups. Steady-state conditions analysis suggested no accumulation during 56 days of once-daily administration. The most frequently observed drug-related adverse events were hypertension (69.5%, 29 grade 1-2 and 3 grade 3-4), proteinuria (47.8%, 16 grade 1-2 and 6 grade 3-4), and hand-foot syndrome (45.6%, 15 grade 1-2 and 6 grade 3-4). Among the thirty-seven evaluable patients, PR was noted in seven patients (18.9%), SD 24 (64.9%), with a disease control rate of 83.8% at 8 weeks.</p> <p>Conclusions</p> <p>The recommended dose of 750 mg once daily was well tolerated. Encouraging antitumor activity across a broad range of malignancies warrants further evaluation in selected populations.</p> <p>Trial registration</p> <p>ClinicalTrials.gov unique identifier: NCT00633490</p